查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
核酸檢測試劑盒市場 2022-2028
市場調查報告書
商品編碼
1215771

核酸檢測試劑盒市場 2022-2028

Nucleic Acid Testing Kits Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

在預測期內，全球核酸檢測試劑盒市場預計將以 7.9% 的複合年增長率顯著增長。 全球核酸檢測試劑盒市場的發展是由於世界各地 COVID-19 的激增，對技術先進的診斷工具的高需求，以及政府和私人機構增加投資以開發新的生物技術診斷技術. 由 除此之外，越來越多地採用核酸檢測來治療遺傳相關疾病、癌症疾病、細菌和病毒感染等，預計將在預測期內推動其需求。

全球核酸檢測試劑盒市場根據疾病檢測和最終用戶進行細分。 基於疾病檢測，市場被細分為冠狀病毒、癌症、肝炎等。 同樣，基於最終用戶，市場被細分為醫院和診所、學術和研究機構。

從地域上看，核酸檢測試劑盒市場分為北美、歐洲、亞太地區和世界其他地區。 預計歐洲在預測期內將出現顯著的市場增長。 英國是一個主要經濟體，對市場貢獻很大。 COVID-19 陽性病例的急劇增加增加了對用於檢測 COVID-19 感染的快速診斷試劑盒的需求。 根據 Worldmeter 的數據，截至 2021 年 5 月 8 日，英國報告的 COVID-19 病例總數為 440 萬。 截至 2021 年 5 月 6 日，英國已在所有四個支柱中進行了 1.58 億次測試（處理或發送）。 該國 COVID-19 診斷測試數量的增加促進了市場的增長。

內容

第 1 章報告概述

  • 當前行業分析和增長前景
  • COVID-19對全球核酸檢測試劑盒行業的影響
  • 全球核酸檢測試劑行業復甦場景
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區

第 2 章市場概述和洞察

  • 調查範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 推薦
    • 總結

第三章競爭格局

  • 主要公司分析
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 關鍵策略分析

第四章市場細分

  • 全球核酸檢測試劑盒市場：按疾病檢測分類
    • 冠狀病毒
    • 癌症
    • 肝炎
    • 其他
  • 全球最終用戶核酸檢測試劑盒市場
    • 醫院和診所
    • 學術和研究機構

第五章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 世界其他地方
    • 拉丁美洲
    • 中東和非洲

第六章公司簡介

  • Abbott Laboratories
  • Agilent Technology, Inc.
  • BGI Group
  • Biomedomics Inc.
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • F.Hoffmann-La Roche AG
  • Henry Schein Inc.
  • Illumina, Inc.
  • Innovita Biological Technology Co. Ltd.
  • Mayo Clinic Laboratories
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • Qiagen N.V.
  • Robert Bosch GmbH
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Danaher Corp.
  • Epitope Diagnostics, Inc.
Product Code: OMR2026827

Title:Global Nucleic Acid Testing Kits Market Size, Share, and Trends Analysis Report, by Disease detection (Coronavirus, Cancer, Hepatitis, and Others), By End-User (Hospital and Clinic, and Academics and Research Institutes), Forecast Periods (2022-2028).

The global nucleic acid testing kits market is anticipated to grow at a substantial CAGR of 7.9% during the forecast period. The global nucleic acid testing kits market growth is being driven by the surging prevalence of COVID-19 in various parts of the globe, and rising investment by government and private agencies for novel biotechnological diagnostic techniques development along with high demand for technologically advanced diagnostic measures. Apart from these, the high adoption of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand during the forecast period.

The global nucleic acid testing kits market is segmented based on disease detection and end-user. Based on disease detection, the market is sub-segmented into coronavirus, cancer, hepatitis, and others. Similarly, based on end-user, the market is sub-segmented into hospitals and clinics, and academics and research institutes.

Geographically, the nucleic acid testing kits market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Europe is expected to show notable growth in the market during the forecast period. The UK is the major economy contributing a significant share to the market. The exponential growth in positive COVID-19 cases gave rise to the demand for quick diagnostic test kits to detect the COVID-19 infection. As per the Worldometer, as of 8th May 2021, the total number of COVID-19 cases reported in the UK was 4.4 million. As of 6th May 2021, there have been 158 million tests (either processed or sent out) conducted across all 4 pillars in the UK. The hike in the number of COVID-19 diagnostic tests in the country boosted the market growth.

The major market players in the global nucleic acid testing kits market include Agilent Technology Inc., Abbott Laboratories, BGI Group, F.Hoffmann-La Roche, PerkinElmer, Inc., and Thermo Fisher Scientific, among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, PerkinElmer, Inc., announced that the USFDA has approved its new coronavirus nucleic acid detection kit for an additional indication that permits the use of saliva as a specimen type. Moreover, in June 2021, Natera, Inc., and BGI Genomics Co., Ltd., (BGI Group) launched the BGI/Natera Signatera Assay. The product has been utilized in numerous clinical studies across non-small cell lung, bladder, breast, and colorectal cancers, to identify molecular residual disease (MRD). Similarly, in May 2020, Beckman Coulter Life Sciences launched RNAdvance Viral XP, a new RNA extraction kit validated for use in infectious disease and real-time PCR virus research.

Research Methodology

The market study of the global nucleic acid testing kits is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Nucleic acid testing kits Research and Analysis by Disease Detection
  • Global Nucleic acid testing kits Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global nucleic acid testing kits market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nucleic acid testing kits market.
  • Insights about market determinants that are stimulating the global nucleic acid testing kits market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Nucleic Acid Testing Kits Industry
  • Recovery Scenario of Global Nucleic Acid Testing Kits Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nucleic Acid Testing Kits Market by Disease detection
    • 4.1.1. Coronavirus
    • 4.1.2. Cancer
    • 4.1.3. Hepatitis
    • 4.1.4. Other
  • 4.2. Global Nucleic Acid Testing Kits Market by End-User
    • 4.2.1. Hospital and Clinics
    • 4.2.2. Academics and Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Agilent Technology, Inc.
  • 6.3. BGI Group
  • 6.4. Biomedomics Inc.
  • 6.5. BioMerieux S.A.
  • 6.6. Bio-Rad Laboratories, Inc.
  • 6.7. Danaher Corp.
  • 6.8. F.Hoffmann-La Roche AG
  • 6.9. Henry Schein Inc.
  • 6.10. Illumina, Inc.
  • 6.11. Innovita Biological Technology Co. Ltd.
  • 6.12. Mayo Clinic Laboratories
  • 6.13. Merck KGaA
  • 6.14. Mylab Discovery Solutions Pvt. Ltd.
  • 6.15. Qiagen N.V.
  • 6.16. Robert Bosch GmbH
  • 6.17. Siemens AG
  • 6.18. Thermo Fisher Scientific, Inc.
  • 6.19. Danaher Corp.
  • 6.20. Epitope Diagnostics, Inc.

LIST OF TABLES

  • 1. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 2. GLOBAL NUCLEIC ACID TESTING KITS FOR CORONAVIRUS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL NUCLEIC ACID TESTING KITS FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL NUCLEIC ACID TESTING KITS FOR HEPATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL NUCLEIC ACID TESTING KITS FOR OTHER DISEASE DETECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 7. GLOBAL NUCLEIC ACID TESTING KITS FOR HOSPITAL AND CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL NUCLEIC ACID TESTING KITS FOR ACADEMICS AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 13. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 14. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 15. EUROPEAN NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY DISEASE DETECTION, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY DISEASE DETECTION, 2021 VS 2028 (%)
  • 2. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 3. GLOBAL NUCLEIC ACID TESTING KITS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL NUCLEIC ACID TESTING KITS FOR CORONAVIRUS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL NUCLEIC ACID TESTING KITS FOR CANCER MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL NUCLEIC ACID TESTING KITS FOR HEPATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL NUCLEIC ACID TESTING KITS FOR OTHER DISEASE DETECTION MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL NUCLEIC ACID TESTING KITS FOR HOSPITAL AND CLINIC MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL NUCLEIC ACID TESTING KITS FOR ACADEMICS AND RESEARCH INSTITUTES MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. US NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. CANADA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. UK NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. FRANCE NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. GERMANY NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. ITALY NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. SPAIN NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. REST OF EUROPE NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. INDIA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. CHINA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. JAPAN NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SOUTH KOREA NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD NUCLEIC ACID TESTING KITS MARKET SIZE, 2021-2028 ($ MILLION)